Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma

Emil Christensen(Aarhus University Hospital), Lars Dyrskjøt(Aarhus University Hospital), Karin Birkenkamp‐Demtröder(Aarhus University Hospital), Alexander Olson(Natera (United States)), Dina Hafez(Natera (United States)), Philippe Lamy(Aarhus University Hospital), Styrmir Sigurjonsson(Natera (United States)), Ramya Srinivasan(University College of Osteopathy), Søren Vang(Aarhus University Hospital), Iver Nordentoft(Aarhus University Hospital), Claus L. Andersen(Aarhus University), Bernhard Zimmermann(Natera (United States)), Sia V. Lindskrog(Aarhus University), Mads Agerbæk(Aarhus University Hospital), Michael Knudsen(Aarhus University Hospital), Ryan Swenerton(Natera (United States)), Zoe J. Assaf(Natera (United States)), Himanshu Sethi(Natera (United States)), Thomas Reinert(Aarhus University Hospital), Alexey Aleshin(Natera (United States)), Raheleh Salari(Natera (United States)), Mustafa Balcioglu(Natera (United States)), Scott Dashner(Natera (United States)), Paul R. Billings(Natera (United States)), Svetlana Shchegrova(Natera (United States)), Jørgen Bjerggaard Jensen(University Psychiatric Hospital), Shruti Sharma(Natera (United States)), Antony Tin(Natera (United States)), Cheng-Ho Jimmy Lin(Natera (United States)), Hsin-Ta Wu(Natera (United States)), Rosalyn Ram(Natera (United States)), Matthew Rabinowitz(Natera (United States)), Samantha Navarro(Natera (United States)), Ann Taber(Aarhus University Hospital)

Journal of Clinical Oncology

May 6, 2019

Cited by 540

Related Papers

|Nature|2019|1.5k

|Science Translational Medicine|2017|1.1k

|JAMA Oncology|2019|992

|Cancer Cell|2016|654

|Nature|2021|603